Bar-Based HIV prevention push shows promise in africa

NCT ID NCT05862857

Completed Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two strategies to encourage HIV prevention pill use among adults who visit or work at drinking venues in Kenya and Uganda. Over 9,000 people took part. One approach focused only on HIV testing, while the other offered broader health screenings. The goal was to see which method helped more people start or continue using PrEP or PEP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, these strategies could help more high-risk adults start and stay on HIV prevention pills, reducing new infections in these communities.
What could go wrong: This is a completed study, but results may not apply to other settings. The interventions were behavioral, so their impact depends on local participation and follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS

Contacts and locations

Locations

Infectious Diseases Research Collaboration (IDRC)

Mbarara, Uganda
Kenya Medical Research Institute (KEMRI)

Mbita, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.